Sam Bankman Fried’s trial hindered by lack of Adderall
October 16, 2023
Attorneys for the FTX founder have inquired about possibly administering extended-release ADHD medication to their client, citing his difficulties maintaining focus throughout the trial. In a letter dated Oct. 15, attorneys for Sam Bankman-Fried reached out to New York District…
- admin
- K33 Research: Crypto markets remain steady despite Binance-DOJ settlement November 29, 2023
- Sei v2 to include EVM compatibility November 29, 2023
- Pando Asset officially files for spot Bitcoin ETF with the SEC November 29, 2023
- Bitcoin Ordinals marketplace Bioniq launches on ICP November 29, 2023
- BIS illustrates how CBDC payments can balance privacy and transparency November 29, 2023